1-3 of 3
Kazimierz Kuliczkowski, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imatinib in Chronic Myeloid Leukemia - Five Years Single Center Experience.

Jaroslaw Dybko, MD, Ewa Medras, MD, Renata Bednarz, MSci, Donata Urbaniak, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2007) 110 (11): 4558.
https://doi.org/10.1182/blood.V110.11.4558.4558
Published: 2007
Journal Articles

Is CD94/NKG2A a Novel Target for Lymphoid Malignancies Immunotherapy?.

Donata Urbaniak-Kujda, PhD, Jaroslaw Dybko, MD, Iwona Prajs, MSci, Marek Kielbinski, PhD, Beata Tomaszewska-Toporska, MD, Katarzyna Kapelko-Slowik, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2006) 108 (11): 4650.
https://doi.org/10.1182/blood.V108.11.4650.4650
Published: 2006
Journal Articles

Bmi-1 Protein Expression in CD34 Positive Acute Myelogenous Leukemia Cells as a Prognostic Factor.

Jaroslaw Dybko, MD, Bozena Jazwiec, MSci, Donata Urbaniak-Kujda, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2006) 108 (11): 4504.
https://doi.org/10.1182/blood.V108.11.4504.4504
Published: 2006